Requires supplement makers to list product details with the FDA, creating a public database for consumers.
This bill would require companies that make or sell dietary supplements to send detailed information about their products to the Food and Drug Administration (FDA). The FDA would then create a public online database where people could look up this information. This would give consumers more details about the supplements they consider buying.
Currently, companies that make or sell dietary supplements are not required to list their products with the Food and Drug Administration (FDA). There is also no public database of this information. This bill would require these companies to submit detailed product information to the FDA. The FDA would then create a publicly searchable electronic database of this information within two years of the bill becoming law. Products that don't comply would be considered misbranded.
S 3677 · 119th Congress · January 15, 2026 · AI Summary by gemini-2.5-flash · 8/10
Sign in to see your representatives' phone numbers
8 filings mentioned this bill
Amounts reflect total quarterly lobbying spend reported to the Senate, not bill-specific spending. Source: Senate LDA filings.